Cytosorbents Corp reports results for the quarter ended in September - Earnings Summary

Cytosorbents

03/11/2022 22:29

* Cytosorbents Corp  CTSO.OQ  reported a quarterly adjusted
loss
of 28 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 16 cents per share.
    * Revenue fell 16.9% to $8.11 million from a year ago;
analysts
expected $8.98 million. 
    * Cytosorbents Corp's reported EPS for the quarter was a
loss
of 28 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Cytosorbents Corp shares had risen by 49.3% this
quarter and
lost 51.6% so far this year.
    * The company reported a quarterly loss of $12.2 million.
    * Wall Street's median 12-month price target for
Cytosorbents Corp
is $8.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 10:29 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.16          -0.28          Missed
 Jun. 30 2022      -0.13          -0.25          Missed
 Mar. 31 2022      -0.12          -0.21          Missed
 Dec. 31 2021      -0.13          -0.21          Missed